ASCO2021 offered insights on the promising dual binding mechanism of bispecific antibodies (BsAbs). Learn more about SmartAnalyst’s perspective on the evolving data, and if it will propel BsAbs forward, despite the challenges.

Click here to learn more: ASCO 2021-Are Two Targets Better Than One?